tag:blogger.com,1999:blog-549949223388475481.post3899841870240930082..comments2024-03-26T22:42:04.176-05:00Comments on Dr. Smith's ECG Blog: ED Case of Catecholaminergic Polymorphic Ventricular TachycardiaUnknownnoreply@blogger.comBlogger9125tag:blogger.com,1999:blog-549949223388475481.post-75316896106042521182020-11-17T15:01:09.240-06:002020-11-17T15:01:09.240-06:00I'm not sure, but I suspect not. I think that...I'm not sure, but I suspect not. I think that most of the catecholaminergic stimulation comes from the adrenal gland (epinephrine) rather than through direct ganglionic sympathetic stimulation.Steve Smithhttps://www.blogger.com/profile/08027289511840815536noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-23979908399824528012020-11-16T22:09:48.359-06:002020-11-16T22:09:48.359-06:00Sorry I'm late to the game. Would this be an ...Sorry I'm late to the game. Would this be an indication to try a stellate ganglion block? I've attached my notion of the idea, as taken from Josh Farkas in the IBCC blog for polymorphic VT storm (not saying that Farkas suggests it here. More asking, would this pathology or presentation be consistent with his pathway for VT storm (without QT prolongation aka not Torsades) https://emcrit.org/ibcc/storm/ Anonymoushttps://www.blogger.com/profile/04337697494921066850noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-29614950798324697962017-01-08T21:11:33.028-06:002017-01-08T21:11:33.028-06:00Thank you for this informational article! I actual...Thank you for this informational article! I actually have CPVT and have been trying to research and learn more about it myself.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-48784720170609037852015-03-02T22:52:14.738-06:002015-03-02T22:52:14.738-06:00Very nice presentation. Bravo.Very nice presentation. Bravo.Dr. Han Naung TUnhttps://www.blogger.com/profile/02683055756158765727noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-31179330446125177832015-02-07T06:07:05.251-06:002015-02-07T06:07:05.251-06:00This was very useful. I am a resident on cardiolog...This was very useful. I am a resident on cardiology.BendoMDhttp://www.bendomd.com/noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-33792515114075398452015-02-06T20:18:26.655-06:002015-02-06T20:18:26.655-06:00Thank you, Ken.Thank you, Ken.Steve Smithhttps://www.blogger.com/profile/08027289511840815536noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-35912990572522049062015-02-06T20:18:13.763-06:002015-02-06T20:18:13.763-06:00Thanks, Christopher!Thanks, Christopher!Steve Smithhttps://www.blogger.com/profile/08027289511840815536noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-86158231432505879552015-02-06T13:57:45.829-06:002015-02-06T13:57:45.829-06:00GREAT post on a less common but important entity. ...GREAT post on a less common but important entity. THANK YOU!ECG Interpretationhttps://www.blogger.com/profile/02309020028961384995noreply@blogger.comtag:blogger.com,1999:blog-549949223388475481.post-55276086021309140632015-02-06T13:41:55.914-06:002015-02-06T13:41:55.914-06:00Leenhardt 2012 (PMID: 23022705) reports that propa...Leenhardt 2012 (PMID: 23022705) reports that propafenone has also been shown to block RyR2 similar to flecainide (but only used in a single case report of resistant CPVT). They also reported that dantrolene is another possible option for resistant CPVT.<br /><br />They too lament the lack of therapeutic strategies, but pointed to ongoing research into RyR2 inhibitors.Christopherhttps://www.blogger.com/profile/11415988855392944633noreply@blogger.com